BioXcel Therapeutics Announces First Patient Enrolled in Phase 1b/2 RELEASE Trial of BXCL501 for the Treatment of Opioid Withdrawal Symptoms

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement